Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
7.57
-0.01 (-0.20%)
Aug 14, 2025, 1:56 PM - Market open

Enanta Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
Net Income
-116.05-133.82-121.76-79-36.17
Upgrade
Depreciation & Amortization
2.342.372.973.333.64
Upgrade
Loss (Gain) From Sale of Assets
0.020.15---
Upgrade
Loss (Gain) From Sale of Investments
-1.14-2.930.33-1.91-3.27
Upgrade
Stock-Based Compensation
26.828.2226.9720.9919.58
Upgrade
Other Operating Activities
2.14-5.17-0.080.2810.41
Upgrade
Change in Accounts Receivable
1.9711.73.26-0.0827.82
Upgrade
Change in Accounts Payable
-0.41-1.15-4.633.77-0.88
Upgrade
Change in Income Taxes
-1-2.298.54-24.21-4.13
Upgrade
Change in Other Net Operating Assets
6.57-0.24-0.376.84-9.91
Upgrade
Operating Cash Flow
-78.76-103.15-84.78-707.09
Upgrade
Operating Cash Flow Growth
-----90.08%
Upgrade
Capital Expenditures
-17.95-9.06-2.13-0.75-1.45
Upgrade
Investment in Securities
76.18-44.5257.0237.7421.28
Upgrade
Investing Cash Flow
58.24-53.5854.936.9919.83
Upgrade
Issuance of Common Stock
0.152.2121.263.6110.48
Upgrade
Other Financing Activities
-27.77195.92-1.23-0.53-1.5
Upgrade
Financing Cash Flow
-27.63198.1320.033.088.98
Upgrade
Net Cash Flow
-48.1641.39-9.85-29.9335.9
Upgrade
Free Cash Flow
-96.71-112.21-86.91-70.755.64
Upgrade
Free Cash Flow Growth
-----91.45%
Upgrade
Free Cash Flow Margin
-142.99%-141.67%-100.87%-72.88%4.61%
Upgrade
Free Cash Flow Per Share
-4.57-5.35-4.22-3.510.28
Upgrade
Cash Interest Paid
11.711.99---
Upgrade
Cash Income Tax Paid
0.244.9-0.030.11
Upgrade
Levered Free Cash Flow
-71.38-62.34-42.08-57.679.55
Upgrade
Unlevered Free Cash Flow
-64.55-59.13-42.08-57.679.55
Upgrade
Change in Working Capital
7.138.026.79-13.6912.9
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q